Xia Jing, Liu Guoxin, Wang Chaofan, Liu Zhuo, Liu Fengyu, Li Hongjuan, Xu Yongqian, Sun Shiguo
College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China.
State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116023, China.
Nanomedicine. 2025 Jan;63:102799. doi: 10.1016/j.nano.2024.102799. Epub 2024 Nov 28.
Disulfiram (DSF), as a sixpenny drug for the treatment of alcohol dependence, has demonstrated copper-dependent chemotherapy (CT) effects in recent years. However, as the most common modality in clinical treatment, prolonged use of CT will lead to multidrug resistance (MDR). In this work, a versatile and ingenious nanoparticle Cu/ZIF-8@DSF@GOx/HA (CZDGH) was constructed to deliver DSF, Cu and GOx to tumor cells. Once internalized by tumor cells, GOx depletes glucose blocking the energy supply leading to ST. Then DSF chelates with Cu in situ to generate CuETs, achieving toxicity-intensified CT, the reduced ATP in this process also inhibits the efflux function of P-gp. In the meantime, Cu consumes glutathione (GSH) to enhance oxidative stress, and the converted Cu catalyzes internal and external sources of HO into •OH, heightening chemodynamic therapy (CDT). The experimental results demonstrate remarkable multimodal synergistic anticancer effects that overcome MDR.
双硫仑(DSF)作为一种治疗酒精依赖的廉价药物,近年来已显示出铜依赖性化疗(CT)效果。然而,作为临床治疗中最常见的方式,长期使用CT会导致多药耐药(MDR)。在这项工作中,构建了一种多功能且巧妙的纳米颗粒Cu/ZIF-8@DSF@GOx/HA(CZDGH),将DSF、铜和葡萄糖氧化酶(GOx)递送至肿瘤细胞。一旦被肿瘤细胞内化,GOx消耗葡萄糖阻断能量供应导致饥饿疗法(ST)。然后DSF与铜原位螯合生成铜-乙二硫醇(CuETs),实现毒性增强的CT,此过程中ATP的减少也抑制了P-糖蛋白(P-gp)的外排功能。同时,铜消耗谷胱甘肽(GSH)以增强氧化应激,转化后的铜将内外源的过氧化氢(HO)催化生成羟基自由基(•OH),增强化学动力学疗法(CDT)。实验结果表明其具有显著的多模式协同抗癌效果,可克服多药耐药。